Stock below Rs 100: Dont miss action in this stock as it has reported more than threefold rise in its PAT and future remains buoyant!
Stock below Rs 100: Dont miss action in this stock as it has reported more than threefold rise in its PAT and future remains buoyant!

Stock below Rs 100: Dont miss action in this stock as it has reported more than threefold rise in its PAT and future remains buoyant!

The company caters to a marquee clientele of Original Equipment Manufacturers (OEMs) and Tier-1 customers in Commercial Vehicle, Tractor, Off-Highway Equipment, Railway & Passenger Vehicle segments.

DSIJ Intelligence-3 Article rating: 4.0

Going forward, performance of Q3FY23 is expected to be largely in-line with Q2FY23 followed by a stronger performance in Q4FY23.   It is on track to achieve a target of Rs 300 crore of revenues from exports in FY23

This PSU stock has jumped from Rs 279 to Rs 726 in the last 3 months
This PSU stock has jumped from Rs 279 to Rs 726 in the last 3 months

This PSU stock has jumped from Rs 279 to Rs 726 in the last 3 months

The stock is up 14 per cent today

DSIJ Intelligence Article rating: 3.3

Sales and net profit for FY22 on a consolidated basis were Rs 5,733 crore and Rs 586 crore, respectively. The company's ROE and ROCE as of the end of the FY22 period are 19.1 and 25.5 per cent, respectively. For the June quarter, on a consolidated basis, the company generated revenue of Rs 2,230 crore and a net profit of Rs 225 crore.    

This 16 per cent dividend-paying stock gives a triangle breakout; do you hold it?
This 16 per cent dividend-paying stock gives a triangle breakout; do you hold it?

This 16 per cent dividend-paying stock gives a triangle breakout; do you hold it?

Ahead of the result of the US Fed's policy meeting later today, investors traded cautiously during today's session. However, this 16 per cent dividend-paying stock surged 3.61 per cent to form a triangle breakout. Continue reading to learn more about this stock.

DSIJ Intelligence Article rating: 3.9

Ahead of the result of the US Fed's policy meeting later today, investors traded cautiously during today's session. However, this 16 per cent dividend-paying stock surged 3.61 per cent to form a triangle breakout. Continue reading to learn more about this stock.

Industry welcomes RBIs CBDC project to launch India's digital currency
Industry welcomes RBIs CBDC project to launch India's digital currency

Industry welcomes RBIs CBDC project to launch India's digital currency

One of the key developments in the financial world is the introduction of Central Bank Digital Currencies (CBDCs)

DSIJ Intelligence-3 Article rating: 4.8

Considering it is governed by a central authority, the volatility risk associated with other digital currencies such as bitcoin is not there while transacting and tracking the transactions will become easier for the government and users alike

Top trending stock below Rs 50: What should investors do with this multibagger fertilizer stock?
Top trending stock below Rs 50: What should investors do with this multibagger fertilizer stock?

Top trending stock below Rs 50: What should investors do with this multibagger fertilizer stock?

In its recent quarterly results, revenue jumped over 42 per cent YoY to Rs 30.20 crore while net profit grew as much as 88 per cent YoY in June 2022.  

DSIJ Intelligence Article rating: 4.1

While fertilizer stocks were a hot topic in 2022 given strong demand and business outlook for the sector, some smallcap and midcap stocks turned multibagger despite market uncertainty.

Stocks to watch: These small-cap stocks will be in focus on Thursday!
Stocks to watch: These small-cap stocks will be in focus on Thursday!

Stocks to watch: These small-cap stocks will be in focus on Thursday!

On Wednesday, domestic equity markets were trading in a constrained range. The markets started out in the green but quickly reversed course.

DSIJ Intelligence Article rating: 4.1

An important event scheduled for later today may be the cause of the gloomy mood.

Alembic Pharma soars 6 per cent after approval from USFDA
Alembic Pharma soars 6 per cent after approval from USFDA

Alembic Pharma soars 6 per cent after approval from USFDA

The shares of Alembic Pharma ended the trading session 5.65 per cent higher at Rs 610.50.

DSIJ Intelligence Article rating: 4.6

Alembic Pharmaceuticals has recently informed the exchange that it has received final approval from US Food & Drug Administration (USFDA) for Mesalamine Extended-Release Capsules. 

 

Overnight Digest: Stocks likely to be in focus on November 3
Overnight Digest: Stocks likely to be in focus on November 3

Overnight Digest: Stocks likely to be in focus on November 3

Keep a watch on these stocks for Thursday's trading session.

DSIJ Intelligence Article rating: 4.1

Breaking the four-day gaining streak, the benchmark indices ended lower with Sensex being down by 215.26 points or 0.35 per cent at 60,906.09 level and Nifty declining 62.60 points or 0.34 per cent at the end of the trading session. Apart from metals and pharma, majority of sectoral indices saw selling during the trading session.

RSS
First18131814181518161818182018211822Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR